Impact Factor 4.716 | CiteScore 4.71
More on impact ›

Correction ARTICLE

Front. Immunol., 17 July 2018 |

Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders

  • 1Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
  • 2Manipal Academy of Higher Education, Manipal, India

A Corrigendum on

Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
by Mohammed S, Harikumar KB. Front Immunol (2017) 8:296. doi: 10.3389/fimmu.2017.00296

In the published article, there was an error regarding the affiliation(s) for Sabira Mohammed. Dr Mohammed should also have an additional affiliation:

Manipal Academy of Higher Education, Manipal, India.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: FTY720, S1PR, asthma, lung diseases, sphingosine 1-phosphate, sphingosine kinase

Citation: Mohammed S and Harikumar KB (2018) Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders. Front. Immunol. 9:1628. doi: 10.3389/fimmu.2018.01628

Received: 29 June 2018; Accepted: 02 July 2018;
Published: 17 July 2018

Approved by: Frontiers in Immunology Editorial Office, Frontiers Media SA, Switzerland

Copyright: © 2018 Mohammed and Harikumar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: K. B. Harikumar,